| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/04/2023 | Vistagen Therapeutics, Inc. | VTGN | Grant | Pre-Funded Warrants (Right to Buy) | 2.8M | $0.00 | $2.8k | By Commodore Capital Master LP | 10/04/2023 |
| 10/04/2023 | Vistagen Therapeutics, Inc. | VTGN | Grant | Tranche 1 Warrants (Right to Buy) | 1.4M | $5.38 | $7.5M | By Commodore Capital Master LP | 10/04/2023 |
| 10/04/2023 | Vistagen Therapeutics, Inc. | VTGN | Grant | Tranche 2 Warrants (Right to Buy) | 1.7M | $8.88 | $15M | By Commodore Capital Master LP | 10/04/2023 |
| 08/07/2023 | Vistagen Therapeutics, Inc. | VTGN | Purchase | Common Stock | 775.8k | $23.15 | $18M | By Commodore Capital Master LP | 08/07/2023 |
| 02/23/2023 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common stock, par value $0.001 per share | 621.75 | $22.07 | $13.7k | By Commodore Capital Master LP | 02/23/2023 |
| 02/23/2023 | Enliven Therapeutics, Inc. | IMRA | Other (acquisition) | Common stock, par value $0.001 per share | 729.9k | $0.00 | $0 | By Commodore Capital Master LP | 02/23/2023 |
| 02/22/2023 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common stock, par value $0.001 per share | 23.6k | $5.11 | $120.5k | By Commodore Capital Master LP | 02/21/2023 |
| 02/21/2023 | Enliven Therapeutics, Inc. | IMRA | Purchase | Common stock, par value $0.001 per share | 8.2k | $5.25 | $43k | By Commodore Capital Master LP | 02/21/2023 |
| 11/14/2022 | Satsuma Pharmaceuticals, Inc. | STSA | Sale | Common Stock, par value $0.0001 per share | 3.2M | $0.71 | $2.3M | By Commodore Capital Master LP | 11/14/2022 |
| 11/24/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 2.9k | $5.42 | $15.8k | By Commodore Capital Master LP | 11/24/2021 |
| 11/22/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 10k | $5.49 | $54.8k | By Commodore Capital Master LP | 11/19/2021 |
| 11/19/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 3.2k | $5.44 | $17.5k | By Commodore Capital Master LP | 11/19/2021 |
| 11/11/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 7.9k | $6.05 | $48k | By Commodore Capital Master LP | 11/10/2021 |
| 11/10/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 9.6k | $5.85 | $56.3k | By Commodore Capital Master LP | 11/10/2021 |
| 11/08/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 560 | $5.99 | $3.4k | By Commodore Capital Master LP | 11/08/2021 |
| 11/05/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 7.8k | $5.95 | $46.4k | By Commodore Capital Master LP | 11/04/2021 |
| 11/04/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 1.4k | $5.88 | $8.2k | By Commodore Capital Master LP | 11/04/2021 |
| 11/02/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 8.9k | $5.64 | $50.1k | By Commodore Capital Master LP | 11/02/2021 |
| 10/29/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 44.7k | $5.71 | $255k | By Commodore Capital Master LP | 10/29/2021 |
| 10/28/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 15.1k | $5.55 | $83.7k | By Commodore Capital Master LP | 10/27/2021 |
| 10/27/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 39.6k | $5.45 | $215.7k | By Commodore Capital Master LP | 10/27/2021 |
| 10/22/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 27.6k | $5.51 | $152.2k | By Commodore Capital Master LP | 10/21/2021 |
| 10/21/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 32.8k | $5.40 | $177.2k | By Commodore Capital Master LP | 10/21/2021 |
| 10/20/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 40.7k | $5.44 | $221.2k | By Commodore Capital Master LP | 10/19/2021 |
| 10/19/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 87.6k | $5.07 | $444k | By Commodore Capital Master LP | 10/19/2021 |
| 10/18/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 36.2k | $4.87 | $176.3k | By Commodore Capital Master LP | 10/15/2021 |
| 10/15/2021 | Satsuma Pharmaceuticals, Inc. | STSA | Purchase | Common Stock, par value $0.0001 per share | 126k | $4.83 | $608.6k | By Commodore Capital Master LP | 10/15/2021 |